Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study

By Liebl A.   Breitscheidel L.   Nicolay C.   Happich M.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2349-2358

Informa Healthcare

Access to resources Recommend Favorite

Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study

By Oguz A.  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 911-920

Informa Healthcare

Access to resources Recommend Favorite

Clinical outcomes and resource use after 24 months of insulin therapy in Turkish patients with type 2 diabetes: subgroup analysis of the TREAT study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 588-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

By Jones Stephen   Benroubi Marian   Castell Conxa   Goday Albert   Liebl Andreas   Timlin Louise   Nicolay Claudia   Simpson Alexander   Tynan Aodan  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 691-700

Informa Healthcare

Access to resources Recommend Favorite

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

By Xie Lin   Wei Wenhui   Pan Chunshen   Baser Onur  

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite